1. Home
  2. FVN vs PETS Comparison

FVN vs PETS Comparison

Compare FVN & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FVN
  • PETS
  • Stock Information
  • Founded
  • FVN 2024
  • PETS 1996
  • Country
  • FVN China
  • PETS United States
  • Employees
  • FVN N/A
  • PETS N/A
  • Industry
  • FVN
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • FVN
  • PETS Consumer Staples
  • Exchange
  • FVN Nasdaq
  • PETS Nasdaq
  • Market Cap
  • FVN 75.6M
  • PETS 118.8M
  • IPO Year
  • FVN 2024
  • PETS N/A
  • Fundamental
  • Price
  • FVN $10.02
  • PETS $5.26
  • Analyst Decision
  • FVN
  • PETS Sell
  • Analyst Count
  • FVN 0
  • PETS 2
  • Target Price
  • FVN N/A
  • PETS $3.50
  • AVG Volume (30 Days)
  • FVN 5.7K
  • PETS 331.9K
  • Earning Date
  • FVN 01-01-0001
  • PETS 02-06-2025
  • Dividend Yield
  • FVN N/A
  • PETS N/A
  • EPS Growth
  • FVN N/A
  • PETS N/A
  • EPS
  • FVN N/A
  • PETS N/A
  • Revenue
  • FVN N/A
  • PETS $259,343,000.00
  • Revenue This Year
  • FVN N/A
  • PETS N/A
  • Revenue Next Year
  • FVN N/A
  • PETS $3.36
  • P/E Ratio
  • FVN N/A
  • PETS N/A
  • Revenue Growth
  • FVN N/A
  • PETS N/A
  • 52 Week Low
  • FVN $9.96
  • PETS $2.90
  • 52 Week High
  • FVN $10.09
  • PETS $7.79
  • Technical
  • Relative Strength Index (RSI)
  • FVN N/A
  • PETS 51.63
  • Support Level
  • FVN N/A
  • PETS $4.82
  • Resistance Level
  • FVN N/A
  • PETS $6.85
  • Average True Range (ATR)
  • FVN 0.00
  • PETS 0.45
  • MACD
  • FVN 0.00
  • PETS -0.10
  • Stochastic Oscillator
  • FVN 0.00
  • PETS 21.67

About FVN Future Vision II Acquisition Corporation Ordinary shares

Future Vision II Acquisition Corp is a blank check company.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: